Multi-Compound Supplement May Improve Vascular Health, Study Finds

Nutrients may improve vascular health

A daily multi-component nutritional supplement can improve endothelial function and reduce arterial stiffness in healthy adults, according to a new study published in European Heart Journal Open, News-Medical reported.

The six-month randomized controlled trial, conducted by researchers at the University of Surrey in the UK, focused on how a combination of vitamins, minerals, amino acids, and plant-derived bioactive compounds affects the biological processes of vascular aging.

Vascular aging involves the gradual structural and functional deterioration of blood vessels, which significantly increases the risk of cardiovascular disease and related mortality. This process is driven by several interconnected factors, including oxidative stress, chronic low-grade inflammation, and mitochondrial dysfunction.

While many bioactive compounds like polyphenols have been studied individually, the researchers sought to understand the potential synergistic benefits of a multi-compound intervention. Using multiple low-dose compounds may allow for the simultaneous targeting of several biological pathways while potentially reducing side effects related to high doses of a single ingredient.

Clinical findings from the Surrey trial

The study followed 61 healthy adults, though the primary analysis was limited to the 43 participants who completed the full six-month duration. The intervention group consumed a daily nutritional powder supplement, while the control group received a similar-looking product without active ingredients.

The results showed physiological changes in the group receiving the supplement. Specifically, the intervention group demonstrated improved endothelial function and a significant reduction in arterial stiffness by the end of the six months. In contrast, the control group showed an increase in arterial stiffness over the same period.

Blood pressure markers also showed a divergence between the two groups. The intervention group experienced a significant reduction in systolic blood pressure at the six-month mark. While the control group saw a much smaller reduction, diastolic blood pressure did not differ significantly between the groups after the intervention period.

The study also noted a slight reduction in the estimated 10-year risk of first-onset atherosclerotic cardiovascular disease in the intervention group. However, researchers noted that because lipid profiles remained comparable between both groups, this risk reduction was driven primarily by the changes in systolic blood pressure rather than changes in cholesterol levels.

Limitations and research gaps

Despite the positive indicators, the researchers emphasized that these findings are preliminary. The study was a relatively small, single-center trial, and the loss of participants during the six-month period limited the overall scope of the data.

One technical challenge noted by the team was the timing of the final assessments. Because measurements were taken approximately 24 hours after the final dose, the researchers could not determine if the observed vascular changes were permanent or merely the result of residual effects from the most recent supplementation.

The study did not assess mechanistic biomarkers in the blood, and therefore cannot explain which specific compound, combinations, or cellular and molecular pathways are driving the observed vascular effects.

The study did not assess actual cardiovascular events, such as heart attacks or strokes. The researchers concluded that larger, longer-term clinical trials are necessary to confirm whether these nutritional improvements actually translate into fewer cardiovascular events or a longer lifespan.

The funding for the study was provided by NOVOS Labs, which also supplied the supplement and control products. While one co-author was employed by the company, the researchers reported that the funder had no role in the study design, the primary analysis, or the interpretation of the findings.

The potential implications of this research extend to middle-aged and older adults looking to manage the multifactorial aging process. If multi-compound interventions can effectively target receptor-mediated signaling or mitochondrial function, they could offer a non-pharmacological approach to mitigating the progression of age-related cerebrovascular and cardiovascular diseases.

Future research will need to identify the exact mechanisms—whether through changes in gut microbiota, enzyme modulation, or improved nitric oxide bioavailability—that allow these nutrients to influence vascular smooth muscle tone and autonomic regulation.

Full study details available via European Heart Journal Open

Keep reading